DrugPatentWatch Database Preview
Drugs in Development Information for Levonordefrin
» See Plans and Pricing
What is the development status for investigational drug Levonordefrin?
Levonordefrin is an investigational drug.
There have been 5 clinical trials for Levonordefrin.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2020.
The most common disease conditions in clinical trials are Pulpitis, Trismus, and [disabled in preview]. The leading clinical trial sponsors are Cairo University, University of Sao Paulo, and Novalar Pharmaceuticals, Inc.
There are one hundred and fifty US patents protecting this investigational drug and one international patent.
Summary for Levonordefrin
| US Patents | 150 |
| International Patents | 1,144 |
| US Patent Applications | 321 |
| WIPO Patent Applications | 466 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2020-10-01) |
| Vendors | 25 |
Recent Clinical Trials for Levonordefrin
| Title | Sponsor | Phase |
|---|---|---|
| Effect of TheraCal Pulpotomy (PT) Pulpotomy Versus MTA Pulpotomy on the Survival Rate of Vital Primary Molars | Cairo University | N/A |
| Effect of Magnesium Sulphate Added to Mepivacaine Hydrochloride on Inferior Alveolar Nerve Block Success in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars: A Randomized Clinical Trial. | Cairo University | N/A |
| Anesthetic Efficacy of %4Alexadricaine Versus %2 Mepicaine-L in Children | Cairo University | Phase 3 |
Clinical Trial Summary for Levonordefrin
Top disease conditions for Levonordefrin
Top clinical trial sponsors for Levonordefrin
US Patents for Levonordefrin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Levonordefrin | Start Trial | Methods and compositions for treating infection | UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS) | Start Trial |
| Levonordefrin | Start Trial | Treatment of sexual dysfunction | Rejoy (Irvine, CA) | Start Trial |
| Levonordefrin | Start Trial | Small molecule agonists of neurotensin receptor 1 | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, CA) | Start Trial |
| Levonordefrin | Start Trial | Cross-linked collagen comprising metallic anticancer agents | MiMedx Group, Inc. (Marietta, GA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Levonordefrin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Levonordefrin | World Intellectual Property Organization (WIPO) | WO2014052836 | 2032-09-27 | Start Trial |
| Levonordefrin | European Patent Office | EP3307280 | 2035-06-11 | Start Trial |
| Levonordefrin | World Intellectual Property Organization (WIPO) | WO2016201286 | 2035-06-11 | Start Trial |
| Levonordefrin | Canada | CA2952732 | 2034-06-25 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
